-
Je něco špatně v tomto záznamu ?
Quality of life of patients with psoriasis
J. Šmejkalová, L. Borská, K. Hamáková, L. Hodačová, E. Čermáková, Z. Fiala
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
Digitální knihovna NLK
Zdroj
NLK
Free Medical Journals
od 2004
ProQuest Central
od 2009-03-01 do Před 6 měsíci
Medline Complete (EBSCOhost)
od 2006-03-01 do Před 6 měsíci
Nursing & Allied Health Database (ProQuest)
od 2009-03-01 do Před 6 měsíci
Health & Medicine (ProQuest)
od 2009-03-01 do Před 6 měsíci
Public Health Database (ProQuest)
od 2009-03-01 do Před 6 měsíci
ROAD: Directory of Open Access Scholarly Resources
od 1993
PubMed
32997478
DOI
10.21101/cejph.a5611
Knihovny.cz E-zdroje
- MeSH
- kvalita života * MeSH
- lidé MeSH
- prospektivní studie MeSH
- psoriáza terapie MeSH
- stupeň závažnosti nemoci MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVE: The two main aims of our study were to assess the quality of life (QOL) of patients with moderate or severe psoriasis treated by Goeckerman therapy and to compare QOL of our patients on the date of admission and 1 month after their discharge. METHODS: We performed a prospective study on 51 patients treated for chronic plaque psoriasis by Goeckerman regimen (GR). The psoriasis area involvement and severity was measured using the Psoriasis Area and Severity Index (PASI). Patients' health-related QOL was evaluated using Psoriasis Disability Index (PDI). RESULTS: In our study we demonstrated that the QOL of this sample of 51 patients with severe forms of psoriasis was relatively good; an average PDI value on the day of admission was 9.02, which represents a small effect on patient's QOL. We did not find any significant differences in QOL between younger and older respondents or between men and women. Despite good treatment efficiency, we did not find improvement in QOL 1 month after discharge. CONCLUSIONS: The QOL of our patients was relatively good. This could be explained by the fact that our patients have been suffering from psoriasis for many years and have probably adapted to their disease. QOL of our patients was not directly dependent on the extent and intensity of skin changes. Further studies on the connection between psoriasis therapy and patients' QOL are still highly needed.
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20015773
- 003
- CZ-PrNML
- 005
- 20201112133505.0
- 007
- ta
- 008
- 201009s2020 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.21101/cejph.a5611 $2 doi
- 035 __
- $a (PubMed)32997478
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Šmejkalová, Jindra, $d 1952- $7 nlk19990074131 $u Department of Hygiene and Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
- 245 10
- $a Quality of life of patients with psoriasis / $c J. Šmejkalová, L. Borská, K. Hamáková, L. Hodačová, E. Čermáková, Z. Fiala
- 504 __
- $a Literatura
- 520 9_
- $a OBJECTIVE: The two main aims of our study were to assess the quality of life (QOL) of patients with moderate or severe psoriasis treated by Goeckerman therapy and to compare QOL of our patients on the date of admission and 1 month after their discharge. METHODS: We performed a prospective study on 51 patients treated for chronic plaque psoriasis by Goeckerman regimen (GR). The psoriasis area involvement and severity was measured using the Psoriasis Area and Severity Index (PASI). Patients' health-related QOL was evaluated using Psoriasis Disability Index (PDI). RESULTS: In our study we demonstrated that the QOL of this sample of 51 patients with severe forms of psoriasis was relatively good; an average PDI value on the day of admission was 9.02, which represents a small effect on patient's QOL. We did not find any significant differences in QOL between younger and older respondents or between men and women. Despite good treatment efficiency, we did not find improvement in QOL 1 month after discharge. CONCLUSIONS: The QOL of our patients was relatively good. This could be explained by the fact that our patients have been suffering from psoriasis for many years and have probably adapted to their disease. QOL of our patients was not directly dependent on the extent and intensity of skin changes. Further studies on the connection between psoriasis therapy and patients' QOL are still highly needed.
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a psoriáza $x terapie $7 D011565
- 650 12
- $a kvalita života $7 D011788
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Borská, Lenka $7 nlk20060173900 $u Department of Pathological Physiology, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
- 700 1_
- $a Hamáková, Květoslava $7 xx0064204 $u Department of Dermatology and Venerology, Faculty Hospital Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Hodačová, Lenka, $d 1966- $7 xx0021920 $u Department of Social Medicine, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
- 700 1_
- $a Čermáková, Eva, $d 1952- $7 mzk2007401286 $u Computer Technology Centre, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
- 700 1_
- $a Fiala, Zdeněk, $d 1955- $7 nlk19990073147 $u Department of Hygiene and Preventive Medicine, Faculty of Medicine in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic
- 773 0_
- $w MED00001083 $t Central European journal of public health $x 1210-7778 $g Roč. 28, č. 3 (2020), s. 219-225
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32997478 $y Pubmed
- 910 __
- $a ABA008 $b B 1829 $c 562 $y p $z 0
- 990 __
- $a 20201009 $b ABA008
- 991 __
- $a 20201112133502 $b ABA008
- 999 __
- $a ok $b bmc $g 1578597 $s 1105939
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 28 $c 3 $d 219-225 $e 20200930 $i 1210-7778 $m Central European Journal of Public Health $n Cent. Eur. J. Public Health $x MED00001083
- LZP __
- $b NLK118 $a Pubmed-20201009
